https://www.bizcommunity.com/196/151.html South Africa Infectious diseases news 15 Infectious Diseases news - South Africa https://www.bizcommunity.com/res/img/logo.gif https://www.bizcommunity.com/196/151.html en-us Wed, 29 Apr 2026 15:49:48 +0200 https://www.bizcommunity.com/article/we-won-the-war-against-these-diseases-then-we-stopped-showing-up-847923a How complacency, not conspiracy, is quietly undoing decades of progress. 1-267709 Wed, 29 Apr 2026 15:09:00 +0200 Bizcommunity Infectious Diseases South Africa https://www.bizcommunity.com/article/biovac-75m-cash-injection-to-boost-vaccine-production-and-create-jobs-958644a Africa is moving closer to creating its first end-to-end multi-vaccine manufacturing facility, as Cape Town-based Biovac has received a €75m cash injection from European investors. The investment will allow Biovac to expand its facility, creating 7,340 jobs and boosting the continent's end-to-end vaccine manufacturing capability. 1-267384 Fri, 17 Apr 2026 07:56:00 +0200 Bizcommunity Infectious Diseases South Africa https://www.bizcommunity.com/article/ai-diagnostics-lands-r85m-to-roll-out-ai-powered-tb-screening-tool-281907a A South African medtech company has obtained R85m in funding to develop its AI-driven tool, enhancing the accessibility of TB screening. 1-267340 Thu, 16 Apr 2026 09:28:00 +0200 Bizcommunity Infectious Diseases South Africa https://www.bizcommunity.com/article/gamechanger-hiv-prevention-drug-lenacapavir-arrives-in-south-africa-392318a The Department of Health has announced the arrival of the first shipment of the HIV prevention drug, Lenacapavir, to the country. The initial batch, totalling about 37,920 doses, was received last week. 1-267143 Thu, 09 Apr 2026 08:07:00 +0200 Bizcommunity Infectious Diseases South Africa https://www.bizcommunity.com/article/clicks-recalls-kiddies-snack-after-non-pathogenic-listeria-detection-622531a Health and wellness retailer Clicks has recalled one of its kids' nutritional products, Made for Tots Corn Puffs Chicken 12g. Affecting 1,152 units — of which 348 have been sold and the remaining 804 removed from shelves — the batch tested positive for non-pathogenic Listeria contamination. 1-266451 Mon, 16 Mar 2026 07:59:00 +0200 Bizcommunity Infectious Diseases South Africa https://www.bizcommunity.com/article/local-production-of-gilead-hiv-drug-in-south-africa-could-boost-access-733722a South Africa is asking local drugmakers to start a process to make Gilead Sciences’ long-acting HIV prevention drug, lenacapavir, domestically, in a push to bring production to the region where it is most needed. 1-266182 Thu, 05 Mar 2026 08:38:00 +0200 Bizcommunity Infectious Diseases South Africa https://www.bizcommunity.com/article/south-african-hivaids-research-receives-r410m-injection-to-offset-us-funding-gap-628491a The South African government will allocate some R410m over the medium term to offset the funding gap in research left after the withdrawal of funding by the United States. This, according to the National Treasury’s 2026 Budget Review released alongside the Budget Speech. 1-265991 Thu, 26 Feb 2026 11:00:00 +0200 Bizcommunity Infectious Diseases South Africa https://www.bizcommunity.com/article/zimbabwe-leads-charge-against-hiv-in-africa-with-lenacapavir-rollout-406689a Zimbabwe's health authorities began administering the long-acting HIV prevention drug lenacapavir, making the country one of the first globally to roll it out as the southern African nation seeks to curb new infections. 1-265805 Fri, 20 Feb 2026 07:50:00 +0200 Bizcommunity Infectious Diseases South Africa https://www.bizcommunity.com/article/cipla-to-secure-south-africa-arv-supply-amid-supplier-crisis-062945a Amid current uncertainty regarding ARV supply in South Africa, Cipla Medpro South Africa has expressed its commitment to providing an uninterrupted supply of critical antiretroviral (ARV) medicines to the Department of Health. 1-265407 Fri, 06 Feb 2026 10:55:00 +0200 Bizcommunity Infectious Diseases South Africa https://www.bizcommunity.com/article/health-dept-assures-sa-there-is-no-immediate-risk-of-nipah-virus-062685a South Africa is currently under “no immediate risk” of the Nipah virus (NiV) outbreak reported in India. This is according to the Department of Health (DoH), which assured in a statement that there is “no need for the public to panic.” 1-265247 Mon, 02 Feb 2026 11:02:00 +0200 Bizcommunity Infectious Diseases South Africa